CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹14 Cr | ₹14 Cr | ₹13 Cr | ₹3.89 Cr | ₹3.89 Cr |
What is the latest Contingent Liabilities ratio of CONCORD BIOTECH ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹14 Cr |
Mar2023 | ₹14 Cr |
Mar2022 | ₹13 Cr |
Mar2021 | ₹3.89 Cr |
Mar2020 | ₹3.89 Cr |
How is Contingent Liabilities of CONCORD BIOTECH Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹14 Cr | 0.00 | |
Mar2023 | ₹14 Cr | 7.43 | |
Mar2022 | ₹13 Cr | 242.57 | |
Mar2021 | ₹3.89 Cr | 0.00 | |
Mar2020 | ₹3.89 Cr | - |
Compare Contingent Liabilities of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹23,750.5 Cr | 4.5% | 0.4% | 54.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,699.0 Cr | 0.6% | -4.6% | 20.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,584.0 Cr | 9.8% | 4.5% | 64.7% | Stock Analytics | |
CIPLA | ₹116,022.0 Cr | -2.9% | -3.9% | 1.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,463.0 Cr | 0.9% | -10.4% | 0.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,434.8 Cr | 0.9% | -0.3% | 27.9% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | 4.5% |
0.4% |
54.7% |
SENSEX | 2% |
0.1% |
8.6% |
You may also like the below Video Courses